Skip to main content
Premium Trial:

Request an Annual Quote

LGC Acquires Link Technologies

NEW YORK (GenomeWeb) – Life sciences tools provider LGC said today that it has acquired Link Technologies, a supplier of specialty reagents for oligonucleotide synthesis.

Following the acquisition, LGC plans to form a new Nucleic Acid Chemistry business unit within its Genomics division that combines Link with its existing Biosearch oligo reagent group and Prime Synthesis CPG business.

Brian Kim, president and managing director of the LGC Genomics division, said in a statement that Link's products are a "great complement" to LGC's, and will provide customers with "an expanded product range, increased supply chain security, improved global logistics, and industry-leading customer support."

Link's customers include oligo synthesis companies, university and commercial research departments, and others in the biotech sector, LGC added.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.